Correlation Between Dyne Therapeutics and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Dyne Therapeutics and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Arrowhead Pharmaceuticals.

Diversification Opportunities for Dyne Therapeutics and Arrowhead Pharmaceuticals

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dyne and Arrowhead is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dyne Therapeutics and Arrowhead Pharmaceuticals

Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 1.45 times more return on investment than Arrowhead Pharmaceuticals. However, Dyne Therapeutics is 1.45 times more volatile than Arrowhead Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest  3,078  in Dyne Therapeutics on August 27, 2024 and sell it today you would lose (109.00) from holding Dyne Therapeutics or give up 3.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dyne Therapeutics  vs.  Arrowhead Pharmaceuticals

 Performance 
       Timeline  
Dyne Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Dyne Therapeutics and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyne Therapeutics and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Dyne Therapeutics and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The idea behind Dyne Therapeutics and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges